Genprex Inc (GNPX) News

Form 8-K - Current report

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive

Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer

Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of...

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024...

Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting

Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for...

Form 8-K - Current report

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes

Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes PR...

Genprex Announces Formation of Mesothelioma Clinical Advisory Board

Genprex Announces Formation of Mesothelioma Clinical Advisory Board PR Newswire AUSTIN, Texas, Sept. 19, 2024...

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024...

Form 8-K - Current report

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1...

Genprex to Present and Participate at Upcoming September Investor and Industry Conferences

Genprex to Present and Participate at Upcoming September Investor and Industry Conferences PR Newswire AUSTIN...

Form 424B5 - Prospectus [Rule 424(b)(5)]